Fluvoxamine but not citalopram increases serum melatonin in healthy subjects – an indication that cytochrome P 450 CYP1A2 and CYP2C19 hydroxylate melatonin C. von BahrC. UrsingS. Röjdmark CLINICAL TRIALS Pages: 123 - 127
Mealtime glucose regulation by nateglinide in type-2 diabetes mellitus Y. H. WalterD. I. SprattJ. F. McLeod CLINICAL TRIAL Pages: 129 - 133
In vitro inhibition screening of human hepatic P 450 enzymes by five angiotensin-II receptor antagonists P. TaavitsainenK. KiukaanniemiO. Pelkonen PHARMAKOKINETICS AND DISPOSITION Pages: 135 - 140
Absorption of effervescent paracetamol tablets relative to ordinary paracetamol tablets in healthy volunteers T. RygnestadK. ZahlsenF. A. Samdal PHARMACOKINETICS AND DISPOSITION Pages: 141 - 143
Modulation of midazolam 1-hydroxylation activity in vitro by neurotransmitters and precursors C. MartínezG. GervasiniJ. Benítez PHARMACOKINETICS AND DISPOSITION Pages: 145 - 151
The pharmacokinetics of caffeine in Nigerian children suffering from malaria and kwashiorkor O. O. AkinyinkaA. SowunmiA. G. Renwick PHARMACOKINETICS AND DISPOSITION Pages: 153 - 158
The effects of acute falciparum malaria on the disposition of caffeine and the comparison of saliva and plasma-derived pharmacokinetic parameters in adult Nigerians O. O. AkinyinkaA. SowunmiA. G. Renwick PHARMACOKINETICS AND DISPOSITION Pages: 159 - 1065
Pharmacokinetics, COX-2 specificity, and tolerability of supratherapeutic doses of rofecoxib in humans M. DepréE. EhrichP. J. De Schepper PHARMACOKINETICS AND DISPOSITION Pages: 167 - 174
The impact of the CYP2D6 and CYP2C19 genotypes on venlafaxine pharmacokinetics in a Japanese population T. FukudaY. NishidaJ. Azuma PHARMACOKINETICS AND DISPOSITION Pages: 175 - 180
Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability R. LagnaouiN. MooreB. Bégaud PHARMACOEPIDEMIOLOGY AND PRESCRIPTION Pages: 181 - 186
Liver injury caused by ebrotidine: a new example of the utility of the postmarketing surveillance J. R. CastilloJ. TorellóA. Hernandez LETTER TO THE EDITOR Pages: 187 - 189
Co-trimoxazole-induced liver and renal failure R. WindeckerJ. SteffenP. A. Thürmann LETTER TO THE EDITOR Pages: 191 - 193